Where Did the Authors Work When They Conducted Their Clinical Pharmacology Studies?

NCT07115680 | Completed

• 1 other identifier: IIS-FJD-RDR-2025-001
• Study Type: observational
• Target: 503
• Locations: 1 country
• Sites: 1

Brief Summary

It is unknown in which countries the clinical pharmacology studies published in leading specialized journals were conducted. The hypothesis is that studies in this specialty tend to be conducted and published by authors from a single country. This analysis aims to describe the number of collaborators and the countries in which they worked, using the Nature Index concept of "share."

Conditions

Scientific Collaboration in Clinical Pharmacology

Keywords

Clinical pharmacology, studies on humans, recently published

Outcome Measures

Primary Outcomes (1)

• countries where authors conducted their study

  The country of the principal authors and of all collaborators will be registered following Nature Index 'share' concept

  Articles of interest to be included from the June 2025 issue backwards until reaching 100 articles or until the January 2024 issue, whichever comes first

Study Arms (1)

Single-country studies

Multinational studies

Other: human participants, data or material

Interventions

human participants, data or material OTHER

Articles on human participants, data, or material published in top (as per JCR IF) clinical pharmacology journals linked to professional societies

Single-country studies

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All original research articles published in the six top clinical pharmacology hybrid journals

You may qualify if:

• Articles on human participants, data or material. Original articles, short reports, research letters.

You may not qualify if:

• In vitro studies, animal studies. Editorials, letters, commentaries, perspectives.

Sponsors & Collaborators

• Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz: lead

Study Sites (1)

Health Research Institute Fundación Jiménez Díaz

Madrid, 28036, Spain

Location

Study Officials

• Rafael Dal-Re, MD, PhD, MPH

  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 4, 2025
• First Posted: August 11, 2025
• Study Start: September 15, 2025
• Primary Completion: November 4, 2025
• Study Completion: November 30, 2025
• Last Updated: December 19, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)